ULENPO Trademark

Trademark Overview

On Thursday, January 9, 2020, a trademark application was filed for ULENPO with the United States Patent and Trademark Office. The USPTO has given the ULENPO trademark a serial number of 88752785. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by Sun Pharmaceutical Industries Limited. The ULENPO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, hormone modifying agents; pharmaceutical preparations for the treatment of cancer, central precocious puberty, endometriosis
ulenpo

General Information

Serial Number88752785
Word MarkULENPO
Filing DateThursday, January 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, hormone modifying agents; pharmaceutical preparations for the treatment of cancer, central precocious puberty, endometriosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSun Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN
Party NameSun Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2022SOU EXTENSION 4 GRANTED
Thursday, June 16, 2022SOU EXTENSION 4 FILED
Thursday, June 16, 2022TEAS EXTENSION RECEIVED
Thursday, December 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, December 14, 2021SOU EXTENSION 3 FILED
Tuesday, December 14, 2021TEAS EXTENSION RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, June 15, 2021SOU EXTENSION 2 FILED
Tuesday, June 15, 2021TEAS EXTENSION RECEIVED
Thursday, December 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 15, 2020SOU EXTENSION 1 FILED
Tuesday, December 15, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 13, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

ulenpo pharmaceutical preparations precocious central puberty endometriosis cancer agents namely hormone